ARC
CLSD

Advisor Resource Council’s Clearside Biomedical CLSD Stock Holding History

Advisor Resource Council’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,000
Closed -$13.8K – 255
2025
Q1 		$13.8K Buy
+1,000
New +$14.4K ﹤0.01% 579

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Advisor Resource Council's CLSD Position: Q2 2025 in Review

Advisor Resource Council sold out of Clearside Biomedical (CLSD) in Q2 2025, closing a stake of 1,000 shares — an estimated $13.8K sold.

Advisor Resource Council first reported a position in CLSD in Q1 2025 and held it in 1 quarter. The position peaked at $13.8K in Q1 2025. 44 funds tracked by Wall St. Rank hold CLSD as of Q2 2025.

  • Advisor Resource Council reported no remaining Clearside Biomedical position as of Q2 2025 after selling out during the quarter.
  • Advisor Resource Council sold 1,000 Clearside Biomedical shares in Q2 2025, an estimated $13.8K.
  • Advisor Resource Council first reported a position in Clearside Biomedical in Q1 2025 and held it in 1 quarter.
  • Advisor Resource Council's Clearside Biomedical position peaked at $13.8K in Q1 2025.
  • 44 funds tracked by Wall St. Rank held Clearside Biomedical as of Q2 2025.

Based on Advisor Resource Council's 13F filing for Q2 2025, filed 11 Aug 2025.